Literature DB >> 7218386

Candidiasis in the burned patient.

M J Spebar, B A Pruitt.   

Abstract

Candida organisms were cultured from 452 of 1,513 hospitalized burned patients during a 6-year study period. Of the 172 patients with colonization of the eschar by this fungus, only 20.7% subsequently developed invasive candidal sepsis. The mortality of untreated Candida burn wound infection was 100%, and with aggressive medical-surgical therapy, 91.6%. Candidemia was present in 52 patients and 76.9% of these died. Candida infection was seen as a preterminal phenomenon, coincident with a generalized collapse of patients' defensive and homeostatic mechanisms. For this reason, mortality was high and the infection rarely responded to treatment. Control of this lethal complication rests with prevention by the judicious use of intravenous broad-spectrum antibiotics and expeditious closure of the burn wound.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7218386     DOI: 10.1097/00005373-198103000-00007

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  13 in total

1.  Fluconazole pharmacokinetics in burn patients.

Authors:  B A Boucher; S R King; H L Wandschneider; W L Hickerson; S D Hanes; V L Herring; T W Canada; M M Hess
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes.

Authors:  A N Neely; E J Law; I A Holder
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

Review 3.  Laboratory diagnosis of invasive candidiasis.

Authors:  J M Jones
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

4.  The role of drugs in management of burns.

Authors:  S P Pegg
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

5.  Characterization of Candida isolates from pediatric burn patients.

Authors:  A N Neely; F C Odds; B K Basatia; I A Holder
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

6.  Effect of proteolytic activity on virulence of Candida albicans in burned mice.

Authors:  A N Neely; I A Holder
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

7.  Properties of a rat monoclonal antibody reactive with both the mannan of Candida species and the O-antigen 6,7 polysaccharide of serogroup C1 salmonellae.

Authors:  N A Nnalue; A Weintraub; A A Lindberg
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Modifications of a Candida albicans biotyping system.

Authors:  C M Childress; I A Holder; A N Neely
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

9.  Fungal infections in cancer patients: an international autopsy survey.

Authors:  G Bodey; B Bueltmann; W Duguid; D Gibbs; H Hanak; M Hotchi; G Mall; P Martino; F Meunier; S Milliken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

10.  Experimental candidiasis after thermal injury.

Authors:  R C Fader; D Nunez; J Unbehagen; H A Linares
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.